Salvage radiation therapy in prostate cancer: relationship between rectal dose and long-term, self-reported rectal bleeding

Por Braide, K., Kindblom, J., Lindencrona, U., Hugosson, J., Pettersson, N.
Publicado no Clin Transl Oncol (2020)

Editorial Comment: A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Por Hugosson, J, Roobol, MJ, Månsson, M, Tammela, TLJ, Zappa, M, Nelen, V, Lott, Felipe
Publicado no Int Braz J Urol (2020)

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual

Por Wever, E M, Hugosson, J, Heijnsdijk, E A M, Bangma, C H, Draisma, G, de Koning, H J
Publicado em 2012

Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey

Por Stranne, J., Axen, E., Franck-Lissbrant, I., Fransson, P., Frånlund, M., Hugosson, J., Khatami, A., Koss-Modig, K., Lodding, P., Nyberg, M., Stattin, P., Bratt, O.
Publicado no World J Urol (2019)

Quality-of-life effects of prostate-specific antigen screening

Por Heijnsdijk, EAM, Wever, EM, Auvinen, A, Hugosson, J, Ciatto, S, Nelen, V, Kwiatkowski, M, Villers, A, Páez, A, Moss, SM, Zappa, M, Tammela, TLJ, Mäkinen, T, Carlsson, S, Korfage, IJ, Essink-Bot, ML, Otto, SJ, Draisma, G, Bangma, CH, Roobol, MJ, Schröder, FH, de Koning, HJ
Publicado no N Engl J Med (2012)

Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data

Por Heijnsdijk, E. A. M., de Carvalho, T. M., Auvinen, A., Zappa, M., Nelen, V., Kwiatkowski, M., Villers, A., Páez, A., Moss, S. M., Tammela, T. L. J., Recker, F., Denis, L., Carlsson, S.V., Wever, E. M., Bangma, C. H., Schröder, F. H., Roobol, M. J., Hugosson, J., de Koning, H. J.
Publicado no J Natl Cancer Inst (2014)

Prostate Cancer Mortality at 11 years of Follow-up in the ERSPC

Por Schröder, FH, Hugosson, J, Roobol, MJ, Tammela, TLJ, Ciatto, S, Nelen, V, Kwiatkowski, M, Lujan, M, Lilja, H, Zappa, M, Denis, LJ, Recker, F, Páez, A, Määttänen, L, Bangma, CH, Aus, G, Carlsson, S, Villers, A, Rebillard, X, Van der Kwast, Th, Kujala, PM, Blijenberg, BG, Stenman, UH, Huber, A, Taari, K, Hakama, M, Moss, SM, de Koning, HJ, Auvinen, A
Publicado no N Engl J Med (2012)

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

Por FitzGerald, L. M., Zhao, S., Leonardson, A., Geybels, M. S., Kolb, S., Lin, D. W., Wright, J. L., Eeles, R., Kote-Jarai, Z., Govindasami, K., Giles, G. G., Southey, M. C., Schleutker, J., Tammela, T. L., Sipeky, C., Penney, K. L., Stampfer, M. J., Gronberg, H., Wiklund, F., Stattin, P., Hugosson, J., Karyadi, D. M., Ostrander, E. A., Feng, Z., Stanford, J. L.
Publicado no Prostate Cancer Prostatic Dis (2018)